This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hoffmann-La Roche Inc., Roche Innovation Center Copenhagen A/s, Other. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hørsholm, DK (2019)
- Horsholm, DK (2017 - 2023)
Company Filing History:
3 out of 5,026 
1 out of 46 
1 out of 834,570 Years Active: 2017-2026
Title: Soren Ottosen: Innovator in Hepatitis B Treatment
Introduction
Soren Ottosen is a notable inventor based in Horsholm, Denmark. He has made significant contributions to the field of medical research, particularly in the treatment of hepatitis B infections. With a total of four patents to his name, Ottosen's work focuses on innovative approaches to combat viral infections.
Latest Patents
Ottosen's latest patents include groundbreaking inventions aimed at reducing the impact of hepatitis B. One of his notable patents is a nucleic acid molecule designed for the reduction of PAPD5 and PAPD7 mRNA. This invention is particularly relevant for treating hepatitis B infections, as it inhibits the expression of both PAPD5 and PAPD7 using a single nucleic acid molecule. Additionally, he has developed a pharmaceutical composition for the treatment and prevention of HBV infections.
Another significant patent involves the use of FUBP1 inhibitors for treating hepatitis B virus infections. This invention focuses on destabilizing cccDNA, specifically HBV cccDNA, and includes nucleic acid molecules such as siRNA, shRNA, and antisense oligonucleotides that are complementary to FUBP1. This innovative approach also encompasses a pharmaceutical composition aimed at treating and preventing HBV infections.
Career Highlights
Throughout his career, Soren Ottosen has worked with prominent companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc. and Roche Innovation Center Copenhagen A/S. His experience in these organizations has contributed to his expertise in developing innovative treatments for viral infections.
Collaborations
Ottosen has collaborated with notable colleagues in his field, including Lykke Pedersen and Maj Hedtjarn. These collaborations have further enhanced his research and development efforts in the area of hepatitis B treatment.
Conclusion
Soren Ottosen is a distinguished inventor whose work has significantly advanced the treatment of hepatitis B infections. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes. His contributions to medical research continue to pave the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile